Clostridioides difficile infection after cardiac surgery: Assessment of prevalence, risk factors and clinical outcomes—retrospective study

Background Clostridioides difficile infection (CDI) is the most common cause of hospital-acquired diarrhea. There is little available data regarding risk factors of CDI for patients who undergo cardiac surgery. The study evaluated the course of CDI in patients after cardiac surgery. Methods Of 6,198 patients studied, 70 (1.1%) developed CDI. The control group consisted of 73 patients in whom CDI was excluded. Perioperative data and clinical outcomes were analyzed. Results Patients with CDI were significantly older in comparison to the control group (median age 73.0 vs 67.0, P = 0.005) and more frequently received proton pump inhibitors, statins, β-blockers and acetylsalicylic acid before surgery (P = 0.008, P = 0.012, P = 0.004, and P = 0.001, respectively). In addition, the presence of atherosclerosis, coronary disease and history of malignant neoplasms correlated positively with the development of CDI (P = 0.012, P = 0.036 and P = 0.05, respectively). There were no differences in the type or timing of surgery, aortic cross-clamp and cardiopulmonary bypass time, volume of postoperative drainage and administration of blood products between the studied groups. Relapse was more common among overweight patients with high postoperative plasma glucose or patients with higher C-reactive protein during the first episode of CDI, as well as those with a history of coronary disease or diabetes mellitus (P = 0.005, P = 0.030, P = 0.009, P = 0.049, and P = 0.025, respectively). Fifteen patients died (21.4%) from the CDI group and 7 (9.6%) from the control group (P = 0.050). Emergent procedures, prolonged stay in the intensive care unit, longer mechanical ventilation and high white blood cell count during the diarrhea were associated with higher mortality among patients with CDI (P = 0.05, P = 0.041, P = 0.004 and P = 0.007, respectively). Conclusions The study did not reveal any specific cardiac surgery-related risk factors for development of CDI.

[1]  J. Wójkowska-Mach,et al.  Long-Term Antibiotic Prophylaxis in Urology and High Incidence of Clostridioides difficile Infections in Surgical Adult Patients , 2020, Microorganisms.

[2]  S. Regenbogen,et al.  Clostridium difficile Infection: An Epidemiology Update , 2020, Clinics in Colon and Rectal Surgery.

[3]  E. Kuijper,et al.  Recurrent community-acquired Clostridium(Clostridioides)difficile infection in Serbianchildren , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  J. Jernigan,et al.  Association between Antibiotic Use and Hospital-Onset Clostridioidesdifficile Infection in U.S. Acute Care Hospitals, 2006-2012: an Ecologic Analysis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Gaughan,et al.  Risk Factors Associated With Recurrent Clostridium difficile Infection , 2018, Journal of clinical medicine research.

[6]  Effect of Empiric Treatment of Asymptomatic Bacteriuria in Neurosurgical Trauma Patients on Surgical Site and Clostridium difficile Infection. , 2018, Neurosurgery.

[7]  J. Garbade,et al.  Evaluation of risk factors for a fulminant Clostridium difficile infection after cardiac surgery: a single-center, retrospective cohort study , 2018, BMC Anesthesiology.

[8]  L. Herrinton,et al.  Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection , 2018, Therapeutic advances in urology.

[9]  K. Carroll,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Mulligan,et al.  Innate, T-, and B-Cell Responses in Acute Human Zika Patients , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Moskowitz,et al.  A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis. , 2018, The Journal of thoracic and cardiovascular surgery.

[12]  K. Carroll,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Linnebur,et al.  Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence , 2017, Therapeutic advances in drug safety.

[14]  H. Nair,et al.  Risk factors for Clostridium difficile infections – an overview of the evidence base and challenges in data synthesis , 2017, Journal of global health.

[15]  E. Larson,et al.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit , 2016, The American Journal of Gastroenterology.

[16]  A. Akram,et al.  Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. , 2016, The Journal of infection.

[17]  D. Leffler,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[18]  F. Barbut How to eradicate Clostridium difficile from the environment. , 2015, The Journal of hospital infection.

[19]  D. Paterson,et al.  Clostridium difficile Infection Seasonality: Patterns across Hemispheres and Continents – A Systematic Review , 2015, PloS one.

[20]  C. Donskey,et al.  Colonization versus carriage of Clostridium difficile. , 2015, Infectious disease clinics of North America.

[21]  D. Paterson,et al.  Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis , 2014, Infection Control & Hospital Epidemiology.

[22]  N. Schiltz,et al.  Analysis of Clostridium difficile infections after cardiac surgery: epidemiologic and economic implications from national data. , 2014, The Journal of thoracic and cardiovascular surgery.

[23]  N. Geller,et al.  Management practices and major infections after cardiac surgery. , 2014, Journal of the American College of Cardiology.

[24]  T. Buchman,et al.  In-hospital mortality after cardiac surgery: patient characteristics, timing, and association with postoperative length of intensive care unit and hospital stay. , 2014, The Annals of thoracic surgery.

[25]  M. P. Bauer,et al.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  A. Tatem,et al.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread , 2010, The Lancet Infectious Diseases.

[27]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[28]  J. Rombeau Increasing Prevalence and Severity of Clostridium difficile Colitis in Hospitalized Patients in the United States , 2008 .

[29]  D. Rothenberger,et al.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. , 2007, Archives of surgery.

[30]  B. Uppal,et al.  Nosocomial diarrhea , 2004, Indian journal of pediatrics.

[31]  T. Sauerbruch,et al.  Clostridium difficile infection in patients with neutropenia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  B. Cunha Nosocomial diarrhea. , 1998, Critical care clinics.

[33]  C. Pothoulakis,et al.  Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. , 1994, The Journal of clinical investigation.

[34]  C. Surawicz,et al.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.